The potential of BACE inhibitors for Alzheimer's therapy.
作者信息
Potter H, Dressler D
机构信息
Huntington Potter is Pfieffer Professor of Alzheimer's Disease Research at the University of South Florida College of Medicine, Tampa, FL, USA.
出版信息
Nat Biotechnol. 2000 Feb;18(2):125-6. doi: 10.1038/72477.
DOI:10.1038/72477
PMID:10657070
Abstract
摘要
相似文献
1
The potential of BACE inhibitors for Alzheimer's therapy.
Nat Biotechnol. 2000 Feb;18(2):125-6. doi: 10.1038/72477.
2
Design and development of BACE-1 inhibitors.
Curr Opin Drug Discov Devel. 2004 Jul;7(4):536-56.
3
New hope on Alzheimer's.
Time. 1999 Nov 1;154(18):84.
4
Progress toward a practical BACE-1 inhibitor.
Curr Opin Drug Discov Devel. 2007 Jul;10(4):383-91.
5
Alzheimer's disease. A firm base for drug development.
Nature. 1999 Dec 2;402(6761):471-2. doi: 10.1038/44973.
6
The potential for BACE1 inhibitors in the treatment of Alzheimer's disease.
IDrugs. 2004 Jul;7(7):653-8.
7
Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
J Neurochem. 2007 Feb;100(3):802-9. doi: 10.1111/j.1471-4159.2006.04260.x.
8
[Drug therapy for aged patients with Alzheimer disease].
Seishin Shinkeigaku Zasshi. 2004;106(1):62-7.
9
Aryl sulfones: a new class of gamma-secretase inhibitors.
Bioorg Med Chem Lett. 2005 May 16;15(10):2685-8. doi: 10.1016/j.bmcl.2004.12.017.
10
Tracking Alzheimer's.
US News World Rep. 1999 Nov 1;127(17):73.
引用本文的文献
1
Potent memapsin 2 (beta-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation.
Bioorg Med Chem Lett. 2008 Feb 1;18(3):1031-6. doi: 10.1016/j.bmcl.2007.12.028. Epub 2008 Jan 3.
2
Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase.
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13554-9. doi: 10.1073/pnas.241509198. Epub 2001 Nov 6.
Zotero 插件